Simultaneous GLP-1 receptor activation and angiotensin receptor blockade increase natriuresis independent of altered arterial pressure in obese OLETF rats

GLP-1 Agonists and Blood Pressure: A Review of the Evidence

(2016) Aditya Goud et al.   CURRENT HYPERTENSION REPORTS

Acute renal haemodynamic effects of glucagon-like peptide-1 receptor agonist exenatide in healthy overweight men

(2016) M. H. A. Muskiet et al.   DIABETES OBESITY & METABOLISM

Short-term effects of liraglutide on kidney function and vasoactive hormones in type 2 diabetes: a randomized clinical trial

(2016) J. Skov et al.   DIABETES OBESITY & METABOLISM

Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial

(2016) Lennart Tonneijck et al.   DIABETOLOGIA

A sodium-glucose co-transporter 2 inhibitor empagliflozin prevents abnormality of circadian rhythm of blood pressure in salt-treated obese rats

(2016) Yui Takeshige et al.   HYPERTENSION RESEARCH

Trends in Obesity Among Adults in the United States, 2005 to 2014

(2016) Katherine M. Flegal et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Glyceraldehyde-derived pyridinium (GLAP) evokes oxidative stress and inflammatory and thrombogenic reactions in endothelial cells via the interaction with RAGE

(2015) Takanori Matsui et al.   Cardiovascular Diabetology

Obesity-Induced Hypertension: Interaction of Neurohumoral and Renal Mechanisms

(2015) J. E. Hall et al.   CIRCULATION RESEARCH

Exenatide Protects Against Glucose- and Lipid-Induced Endothelial Dysfunction: Evidence for Direct Vasodilation Effect of GLP-1 Receptor Agonists in Humans

(2015) Juraj Koska et al.   DIABETES

GLP-1 Response to Oral Glucose Is Reduced in Prediabetes, Screen-Detected Type 2 Diabetes, and Obesity and Influenced by Sex: The ADDITION-PRO Study

(2015) Kristine Færch et al.   DIABETES

Effect of dipeptidyl peptidase-4 inhibition on circadian blood pressure during the development of salt-dependent hypertension in rats

(2015) Abu Sufiun et al.   HYPERTENSION RESEARCH

Diuretic and Natriuretic Effects of Dipeptidyl Peptidase-4 Inhibitor Teneligliptin

(2015) Masao Moroi et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Role of the Na+/H+ exchanger 3 in angiotensin II-induced hypertension

(2015) Xiao C. Li et al.   PHYSIOLOGICAL GENOMICS

Time course and mechanisms of the anti-hypertensive and renal effects of liraglutide treatment

(2014) B. J. von Scholten et al.   DIABETIC MEDICINE

Identification and Characterization of GLP-1 Receptor-Expressing Cells Using a New Transgenic Mouse Model

(2013) P. Richards et al.   DIABETES

Glucagon-Like Peptide-1 (GLP-1): Effect on Kidney Hemodynamics and Renin-Angiotensin-Aldosterone System in Healthy Men

(2013) Jeppe Skov et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure

(2013) Minsuk Kim et al.   NATURE MEDICINE

GLP-1 receptor activated insulin secretion from pancreatic β-cells: mechanism and glucose dependence

(2012) A. R. Meloni et al.   DIABETES OBESITY & METABOLISM

Angiotensin Receptor Blockade Increases Pancreatic Insulin Secretion and Decreases Glucose Intolerance during Glucose Supplementation in a Model of Metabolic Syndrome

(2012) Ruben Rodriguez et al.   ENDOCRINOLOGY

Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers and Diabetes: A Meta-Analysis of Placebo-Controlled Clinical Trials

(2011) G. Tocci et al.   AMERICAN JOURNAL OF HYPERTENSION

Acute Cholesterol-induced Anti-natriuretic Effects

(2010) Mouhamed S. Awayda et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Systolic Heart Failure

(2010) John J.V. McMurray   NEW ENGLAND JOURNAL OF MEDICINE

Exendin-4 has an anti-hypertensive effect in salt-sensitive mice model

(2009) Kunio Hirata et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Differences in the Central Anorectic Effects of Glucagon-Like Peptide-1 and Exendin-4 in Rats

(2009) Jason G. Barrera et al.   DIABETES

Strict angiotensin blockade prevents the augmentation of intrarenal angiotensin II and podocyte abnormalities in type 2 diabetic rats with microalbuminuria

(2009) Akira Nishiyama et al.   JOURNAL OF HYPERTENSION

Validation of simple indexes to assess insulin sensitivity during pregnancy in Wistar and Sprague-Dawley rats

(2008) J. Cacho et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Hydrochlorothiazide, but not Candesartan, Aggravates Insulin Resistance and Causes Visceral and Hepatic Fat Accumulation

(2008) Jan W. Eriksson et al.   HYPERTENSION

The incretin system and its role in type 2 diabetes mellitus

(2008) J HOLST et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY